Buying Signals
Enter your access code to continue
Buying Signals
News classified by trigger type. Filter to find the actionable signals for your verticals.
All 4193 Expansion 67 Capex 13 Leadership 11 Partnership 21 Closure 23 Recall 5 Regulatory 26 Earnings 219 Other 200 Untagged 3608
Showing 200 of 4193 articles (last 90 days, newest first)
Lantheus: The Turnaround Is Working, But The Easy Money Has Been Made (NASDAQ:LNTH) - Seeking Alpha
Estée Lauder (EL) Stock After Recent Slide Are Valuation Estimates Now Attractive - Yahoo Finance
MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut - Yahoo Finance
Celsius is Already Generating Strong Proft Margins
The management team is confident the margins can go higher still.
Brown-Forman Stock - long-term whiskey business under scrutiny after cash flow update - AD HOC NEWS
Estée Lauder Companies (EL) Stock Could Be 28.5% Undervalued After Scent Scanner Launch - simplywall.st
Hanesbrands Stock - Long-term business model under scrutiny - AD HOC NEWS
Estée Lauder Companies (EL) Stock Could Be 11% Undervalued on Its Margin Recovery Story - Yahoo Finance
Drone-Transported Organ Donations - Trend Hunter
This Dividend Portfolio Pays More Than Social Security and a Part-Time Job Combined
The average retired worker receives about $24,000 a year from Social Security. Add a modest part-time job, the kind many retirees take for supplemental income rather than career advancement, and total annual income often lands somewhere between $40,000 and $45,000 before taxes. For millions of retirees, that combination defines the retirement budget. A portfolio can... This Dividend Portfolio Pays
NASA Just Flew Human Kidneys By BVLOS Drone - DroneXL.co
Zoetis Deadline: ZTS Investors with Losses in Excess of $100K Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit
NEW YORK, June 20, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. So What: If you purchased Zoetis securities during the Class Period you may be entitled to compensation without pa
Can the US compete with Asian megafactories making American jeans? - Yahoo News Canada
AbbVie would gain an experimental eczema drug by buying biotech: report
AbbVie is reportedly trying to buy a biotech company that is developing a promising atopic dermatitis drug for $10.9 billion in cash, according to a Financial Times report.
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?
Intellia Therapeutics is leveraging its strategic partnership with Regeneron to advance a deep pipeline of CRISPR-based gene editing therapies. Omeros recently entered the commercial stage with the FDA approval of Yartemlea and a significant development deal with Novo Nordisk.
The Campbell's Company - Sell: Structural Problems Are Serious
The deterioration in Campbell's gross and operating margins has been ongoing for an extended time period and seems to be accelerating. Q3, 2026 reported results met expectations with a sales match and an earnings beat of $0.02. However, future quarters will be challenging. An examination of standard metrics measuring Fixed Asset usage reveals inefficiencies that are structural in nature and are in
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Black Rock Coffee Bar, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BRCB
NEW YORK, June 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Black Rock Coffee Bar, Inc. (NASDAQ: BRCB): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement”) issued in connection with Black Rock Coffee's September
A Hidden Gas Price Spike Is Coming — and It Has Nothing to Do With Iran
Many investors and drivers breathed a sigh of relief after the 2024 election.
Will SpaceX Stock Be Higher or Lower in 1 Year? Here's My Honest Take
SpaceX's stock is up by nearly 40% in just over a week since its IPO. There are some solid bull arguments to be made about the company.
Energizer Holdings (ENR) Stock Could Be 76.8% Below Fair Value As Institutions Circle - simplywall.st
3 Stocks That Have Made Long-Term Investors Rich and Could Do It Again
June is a natural moment for mid-year reflection. Short-term traders are squaring quarterly books, but long-term investors should be doing something different: stepping back to ask which businesses have already produced multi-decade compounding, and whether the moats that drove those returns are still intact today.
Why Diageo, Heineken and Anheuser-Busch are battling falling alcohol demand
Alcohol companies have had fewer reasons to say "cheers" in recent years. Volumes have been falling, and the entire business model is undergoing a structural shakeup as younger people drink less.
Where to Put $1,000 When the Market Is This Uncertain
Church & Dwight's volume-driven growth, Keurig Dr Pepper's expanding energy drink portfolio, and Kenvue's strong beauty segment show these companies are finding ways to grow beyond simply passing inflation on to customers. None of these stocks are likely to be overnight winners, but their strong brands, cash generation, and long-term growth opportunities make them compelling choices for investors
Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up.
Vertex Pharmaceuticals and Eli Lilly are both going after the non-opioid pain management market. Vertex Pharmaceuticals has a lead, but both drugmakers could be successful in this niche.
Edgewell Personal Care (EPC) Is Up 6.7% After Guidance Cut And Inflation Rotation Debate Shift - simplywall.st
BRCB Investors Have Opportunity to Lead Black Rock Coffee Bar, Inc. Securities Lawsuit
NEW YORK, June 19, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of Black Rock Coffee Bar, Inc. (NASDAQ: BRCB): (i) Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Black Rock Coffee's September 202
His 'SuperPretzel' Became a Staple in Stadiums, Malls - Newser
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, Deadline - Contact KTMC
Did you buy ZTS securities between January 14, 2025, and May 6, 2026? Affected ZTS Investor Summary Who: Zoetis Inc. (NYSE: ZTS) What: Securities fraud class action lawsuit filed Class Period: January 14, 2025 through May 6, 2026 Deadline to Seek Lead Plaintiff Status: Juy 27, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company's product adoption.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif. , June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44,409 restricted stock units of the company's common stock to 15 newly hired non-executive officers of the company.
The $1 Million Retirement Mistake: Counting Income You’ll Never Get to Spend
A $1 million portfolio is often discussed as though the balance itself answers the retirement question. It does not. What matters is the amount of income that ultimately reaches your bank account after taxes. The yield displayed on a brokerage statement is only the starting point. Federal taxes, state taxes, and the type of income... The $1 Million Retirement Mistake: Counting Income You'll Never
Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton
Alkermes plc maintains a Buy rating, driven by the accretive Avadel Pharmaceuticals acquisition and strong pipeline progress. Company bolstered its hypersomnolence portfolio with LUMRYZ, which delivered robust early sales and revenue momentum post-acquisition. Positive phase 2 data for alixorexton in narcolepsy type 2 and ongoing phase 3 Brilliance Studies underpin a compelling growth thesis.
Phibro Animal Health Corporation: Stable But Limited Near-Term Upside (NASDAQ:PAHC) - Seeking Alpha
The Retirement Portfolio That Forks Over a $10,000 Check Every Month
Ten thousand dollars a month works out to $120,000 a year, an income stream that exceeds the roughly $68,359 in per-capita disposable personal income reported by the Bureau of Economic Analysis for the first quarter of 2026. For many retirees, that level of cash flow would support a lifestyle well above basic needs. The real... The Retirement Portfolio That Forks Over a $10,000 Check Every Month
PVH Stock Tracks Key Trends in DTC, AI and Apparel Margins
PVH is boosting DTC growth, digital execution and inventory discipline, but tariffs and softer EMEA demand continue to cloud the outlook.
Is PVH Stock a Value Buy After Earnings Strength and Flat Sales?
PVH combines low valuation multiples and digital momentum with earnings strength, but tariffs and weaker EMEA demand temper the outlook.
PVH Stock Outlook Hinges on Brands, Digital Growth and Tariffs
PVH is balancing Calvin Klein and Tommy Hilfiger momentum with digital growth and inventory discipline as tariffs and EMEA weakness weigh on outlook.
ZOETIS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline.
Good Culture to invest in MMPA’s Remus cottage cheese facility - Michigan Farm News
Gerald Shreiber, Who Turned the Soft Pretzel Into a Ubiquitous Stadium Snack, Dies at 84 - WSJ
Lantheus (LNTH) Proxy filing Summary - Quartr
Is Fomento Economico (FMX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Fomento Economico (FMX) possesses solid growth attributes, which could help it handily outperform the market.
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Black Rock Coffee Bar, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Black Rock (BRCB) To Contact Him Directly To Discuss Their Options
Smart Money Is Fleeing Tech for Johnson & Johnson Ahead of the Next Market Storm
Bear markets typically follow periods of extreme enthusiasm. The technology sector has been driving the market higher, and it may be time to hedge your bets a little with a stock like Johnson & Johnson.
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
Amgen delivers robust cash flow and high net margins through its established portfolio of blockbuster medications. NovoCure offers a unique direct-to-patient model for tumor treatment, targeting niche oncology markets with tumor-treating electrical fields.
Johnson & Johnson (JNJ) Could Be a Great Choice
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
IART vs. SONVY: Which Stock Is the Better Value Option?
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?
V.F. (VFC) Up 7.1% Since Last Earnings Report: Can It Continue?
V.F. (VFC) reported earnings 30 days ago. What's next for the stock?
Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm
New York, New York--(Newsfile Corp. - June 19, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all pers
Here's How Many Shares of Coca-Cola You'd Need to Buy for $1,000 in Yearly Dividends
Coca-Cola pays $2.12 per share annually, putting the dividend yield at roughly 2.65%. You'd need about 472 shares, worth approximately $37,760, to generate $1,000 in yearly dividends.
AbbVie nears $11 billion deal for Apogee Therapeutics, FT reports
AbbVie is nearing a deal to acquire inflammatory disease drug developer Apogee Therapeutics for about $10.9 billion in cash, the Financial Times reported on Friday, citing people familiar with the matter.
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Black Rock Coffee Bar, Inc. (BRCB)
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities who purchased or otherwise acquired Black Rock Coffee Bar, Inc. (“Black Rock Coffee” or the “Company”) (NASDAQ: BRCB) securities between September 12, 2025
CF vs. NTR: Which Fertilizer Giant Is the Better Pick Now?
CF Industries and Nutrien ride firm fertilizer demand and higher prices as global farm economics stay supportive.
Buy 5 Non-Tech Wide Moat Stocks for a Stable Portfolio in 2H 2026
CAT, V, SBUX, KO and EL are five non-tech wide-moat stocks positioned for stable returns in 2H 2026.
Will Keurig's Brand Strength & Strategic Actions Power Growth?
KDP is fueling growth through coffee leadership, product innovation, premiumization and productivity while expanding into faster-growing beverage categories.
Archer Daniels' Innovation, Cost Discipline and Nutrition Aid Growth
ADM is advancing cost savings, innovation and digital initiatives while strengthening Nutrition and streamlining operations to support long-term growth.
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Volume Mix Strength at Keurig: Is Demand Outpacing Pricing?
KDP's Q1 volume/mix gains and U.S. Refreshment Beverages momentum suggest growth may be moving beyond pricing-driven gains.
Are Investors Undervaluing Archer Daniels Midland (ADM) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are Investors Undervaluing Fomento Economico Mexicano (FMX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Coca-Cola (KO) Stock Outpacing Its Consumer Staples Peers This Year?
Here is how Coca-Cola (KO) and Altria (MO) have performed compared to their sector so far this year.
Should Value Investors Buy CF Industries (CF) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is VAREX IMAGING (VREX) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is BUNGE GLOBAL SA (BG) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Bunge Global (BG) and Lifezone Metals Limited (LZM) have performed compared to their sector so far this year.
The Gross Law Firm Reminds Zoetis Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 27, 2026 - ZTS
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zoetis Inc. (NYSE: ZTS).
McCormick (MKC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for McCormick (MKC), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended May 2026.
HELE Deadline Alert: The Gross Law Firm Reminds Helen of Troy Limited (HELE) Investors of Securities Class Action Deadline on August 3, 2026
NEW YORK, June 19, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Helen of Troy Limited (NASDAQ: HELE).
Craig-Hallum Sticks to Their Buy Rating for MiMedx Group (MDXG) - The Globe and Mail
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
If You Think The Market Will Ever Fall, Buy This
The stock market isn't going to fall again, at least in this century. The S&P is up 8% this year. It is up 25% in the last year, and 80% over the last five. Some stocks of relatively well-known companies have doubled or better since January 1. Among the most extraordinary is the dying chip... If You Think The Market Will Ever Fall, Buy This
1 Dividend Powerhouse Retirees Can Lean On Even If Rates Hike
Philip Morris International (NYSE:PM | PM Price Prediction) is a tobacco giant in the middle of a profitable pivot, with smoke-free products now accounting for over 43% of net revenues through IQOS heat-not-burn devices and ZYN nicotine pouches.
AbbVie: Immunology Cash Flow Funds Oncology Expansion
I continue to cover AbbVie with a 'Buy' rating due to its R&D achievements. So, in the past 3 months, Decnupaz and Skinvive by Juvederm have received FDA approvals. Moreover, a week ago, AbbVie reported promising results from the Phase 3 CLL14 trial for the treatment of chronic lymphocytic leukemia patients.
River Road Asset Management LLC Purchases Shares of 917,670 AptarGroup, Inc. $ATR - MarketBeat
Rising Cost-of-Living Pressures? Why Retirees Should Buy This High-Yield Dividend Legend and Never Look Back
Retirees watching grocery bills climb need income that grows faster than the receipt.
HELE Investors Have Opportunity to Lead Helen of Troy Limited Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 19, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Helen of Troy Limited (“Helen of Troy” or “the Company”) (NASDAQ: HELE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Interface (TILE) Moves 5.3% Higher: Will This Strength Last?
Interface (TILE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Bruker Gains 50.3% in a Year: What's Driving the Rally?
BRKR's rally is fueled by BSI NANO growth, AI-driven metrology demand and gains in preclinical imaging despite tariff pressures.
Strength Seen in Energizer (ENR): Can Its 7.8% Jump Turn into More Strength?
Energizer (ENR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BALI: A Hidden Covered Call ETF That Could Be Better Than You Think
iShares US Large Cap Premium Income Active ETF (BALI) targets conservative, income-focused investors seeking high yield with lower volatility than the broader market. BALI offers a 7.8% distribution yield and a low 0.35% expense ratio, outperforming some covered call peers in recent periods while maintaining a conservative cost structure. The ETF's options overlay strategy caps upside, leading to
NVST Stock Rallies 37.1% in a Year: What's Behind the Drive?
Envista rises 37.1% in a year as new dental product launches, margin gains, acquisitions and a strong balance sheet fuel growth.
J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?
J&J's shares fall 3% in three months despite solid results and pipeline progress, raising questions about whether the pullback is a buying opportunity.
Inherited Stock Resets Its Tax Bill to Zero and Here’s the IRS Rule That Does It
If you've ever inherited a stock portfolio, a rental property, or even a single share of grandma's old utility company, the IRS hands you a quiet gift most heirs never notice. It's called the step-up in basis, and it can wipe out decades of capital gains tax in a single moment. The rule resets the... Inherited Stock Resets Its Tax Bill to Zero and Here's the IRS Rule That Does It
Starbucks Could Double Its International Store Count. Is It Time to Invest $1,000?
More than 10,000 of those new stores will be in China. The new CEO's turnaround plan seems to be working.
Constellation Brands Looks Ready For A World Cup Boost (Earnings Preview)
Constellation Brands is upgraded to a cautious Buy ahead of Q1 earnings, anticipating positive management commentary. The upcoming FIFA World Cup could create a meaningful demand tailwind, particularly because most matches occur in key North American markets served by Constellation. Management plans aggressive brand investment around the tournament, potentially boosting sales volumes and improving
Should You Buy Costco Stock for the Long Haul? Here's the Honest Answer.
Costco is highly respected by its customer base and the investment community. The company is posting respectable growth numbers, but they may not justify the stock's current valuation.
Does Energizer (ENR) Offer Hidden Value Despite Weak Results and Heavy Institutional Buying? - simplywall.st
Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases
First-in-human Phase 1 study in 56 healthy participants demonstrated KIT2014's safety and tolerability KIT2014 is being developed as an inhalation therapy for respiratory diseases including chronic obstructive pulmonary disease (COPD), non-CF bronchiectasis (NCFB) and cystic fibrosis (CF) KIT2014's unique mode of action improves respiratory symptoms by promoting bronchodilation and reducing lung i
Tranche Update on AptarGroup, Inc.'s Equity Buyback Plan announced on October 10, 2024. - marketscreener.com
AptarGroup (ATR) Stock Could Be 25.5% Undervalued on Its Drug Delivery Growth Narrative - simplywall.st
USANA Health Sciences: How The Restructuring Plan Makes It A Strong Buy
USANA Health Sciences is undergoing restructuring, causing temporary margin pressure but positioning for significant future profit expansion. Rise Wellness posted 740% revenue growth, but gross margin fell to 7.1% due to promotional discounts; margin recovery is expected as restocking begins at regular prices. Hiya's revenue dropped 13.3% amid higher CAC from Meta algorithm changes; in-house manuf
Black Rock Coffee Bar: Give This Company The Benefit Of The Doubt As It Expands Footprint
Black Rock Coffee Bar has suffered a two-thirds drop since its September IPO, now trading near $8, reflecting market bias against small caps. I reiterate a buy rating, emphasizing that recent sales deceleration and moderated growth are already priced in, making BRCC a bona fide value name. BRCC targets expanding from ~200 to over 1,000 stores by 2035, with mid-single-digit same-store sales growth
Aptar Releases 2025 Corporate Sustainability Report - Aptar
Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that C. Raymond Larkin, Jr. will retire as Chairman of the Board effective J
Brown-Forman (NYSE: BF) details 2026 meeting, director slate and pay policies - Stock Titan
Brown-Forman Reports Financial Results - Fred Minnick
PAHC News | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Investor Notice: Robbins LLP Informs Investors of the Black Rock Coffee Bar, Inc. Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)---- $BRCB #Coffee--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) securities between September 12, 2025 and May 12, 2026. Black Rock Coffee Bar, Inc. owns and operates a chain of drive-through coffee bars.For more information, submit a form, email att
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
Zoetis (ZTS) concluded the recent trading session at $78.71, signifying a +1.88% move from its prior day's close.
Vital Farms (VITL) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, Vital Farms (VITL) stood at $10.41, denoting a -4.06% move from the preceding trading day.
Valero Energy (VLO) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, Valero Energy (VLO) closed at $236.3, marking a -1.45% move from the previous day.
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, Merck (MRK) stood at $113.87, denoting a -1.36% move from the preceding trading day.
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $451.63, denoting a -1.6% move from the preceding trading day.
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
In the most recent trading session, AbbVie (ABBV) closed at $216.49, indicating a -2.14% shift from the previous trading day.
Johnson & Johnson (JNJ) Stock Slides as Market Rises: Facts to Know Before You Trade
Johnson & Johnson (JNJ) reached $228.39 at the closing of the latest trading day, reflecting a -2.48% change compared to its last close.
Celsius Holdings Inc. (CELH) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Celsius Holdings Inc. (CELH) closed at $30.8, marking a +1.38% move from the previous day.
Hair Relaxer Lawsuit | Cash Settlements & Lawyers (June 2026) - Sokolove Law
ZTS INVESTOR NOTICE: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit
/PRNewswire/ -- Robbins Geller Rudman and Dowd LLP announces that purchasers or acquirers of Zoetis Inc. (NYSE: ZTS) securities between January 14, 2025 and May
ZOETIS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ZTS
New York, New York--(Newsfile Corp. - June 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Zoetis Inc. (NYSE: ZTS) between January 14, 2025 and May 6, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff deadline. SO WHAT: If you purchased Zoetis securities during the Class Period you may be entitled to compensa
Coffee Prices Are Heating Up. Is It a Rally or a Trap?
Heavy rain in Brazil, the world's largest coffee producer, has disrupted the harvest and raised concerns about bean quality.
HanesBrands Inc (HBI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Implied Volatility Surging for Vita Coco Options
Investors need to pay close attention to COCO stock based on the movements in the options market lately.
AbbVie Declares Quarterly Dividend
NORTH CHICAGO, Ill., June 18, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.
ScottsMiracle-Gro Appoints Nick Miaritis to Executive-Level Chief Brand Officer Position
MARYSVILLE, Ohio, June 18, 2026 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today announced that Nick Miaritis has been named executive vice president and chief brand officer, a new position overseeing the Company's brands and leading all its marketing strategies and initiatives. The appointment
The Andersons, Inc. Declares Cash Dividend for Third Quarter 2026
MAUMEE, Ohio, June 18, 2026 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) announces a third quarter 2026 cash dividend of 20 cents ($0.20) per share payable on July 22, 2026, to shareholders of record as of July 01, 2026. This is The Andersons 119th consecutive quarterly cash dividend since listing on the Nasdaq in February 1996.
Constellation Brands heads into earnings with demand headwinds
Constellation Brands Inc (NYSE:STZ) reports fiscal first-quarter results after the close on June 30, and the setup is bumpy. UBS is modeling EPS of $3.12, below the Street consensus of $3.24, after cutting estimates to reflect weaker beer demand.
Solésence Named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards
Global Award Recognizes Excellence in Service, Reliability, and Innovation ROMEOVILLE, Ill., June 18, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc.
Yulee man pleads guilty in $5.7M fraud against Swisher International - JaxToday
Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors that a Class Action Lawsuit Has Been Filed Against Zoetis and Encourages Investors to Contact the Firm Before the July 27th Deadline
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Zoetis (ZTS) To Contact Him Directly To Discuss Their Options
UFP Technologies Director Sells $287,000 After Option Exercise as Shares Stay Flat
A director of UFP Technologies sold 1,200 shares for approximately $287,000 on June 12, 2026, via an option exercise and immediate disposition at around $239.29 per share. This trade represented 18% of Feldmann's direct common stock holdings at the time of the transaction, reducing her directly held shares from 6,676 to 5,476.
BLCR: A Top Performing Active Large Cap ETF Worth Watching
The iShares Large Cap Core Active ETF is a highly concentrated, actively managed fund that has outperformed many similar ETFs since its inception in October 2023. BLCR's managers intentionally deviate from consensus, focusing on long-term earnings growth and momentum, differentiating it from passive Index funds. Fundamental analysis reveals an expensive portfolio, both relative to its peers and it
New Mexico Bioscience Delegation Showcases Innovation and Industry Growth at BIO International Convention 2026
Albuquerque, NM, June 18, 2026 (GLOBE NEWSWIRE) -- A delegation of economic development, research, healthcare, and industry leaders will represent New Mexico's growing bioscience sector at the BIO International Convention, taking place June 22–25, 2026, in San Diego, California. Led by the Albuquerque Regional Economic Alliance (AREA), the delegation will promote New Mexico's bioscience industry,
BLADE AND BOW UNVEILS A NEW LIMITED ANNUAL EXPRESSION, 12-YEAR-OLD SOLERA RESERVE
LOUISVILLE, Ky., June 18, 2026 /PRNewswire/ -- Blade and Bow announces its 12-Year-Old Solera Reserve, a new limited annual expression crafted at the intersection of time and technique by Nicole Austin, the Director of American Whiskey Liquid Development and Capabilities at Diageo. Beginning with a 12–Year–Old Blade and Bow Kentucky Straight Bourbon, it's guided through a multi–vat Solera finishin
Living Longer Is Big Business. These Stocks Will Benefit.
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 billion.
AB InBev's Premiumization and Digital Transformation Drive Growth
BUD drives growth through premiumization, digital platforms and Beyond Beer expansion while strengthening revenue momentum across key markets.
Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
PEN gains CE Mark in Europe for THUNDERBOLT, expanding stroke treatment access and advancing its global stroke care strategy.
FTC requiring Aurobindo Pharma to divest from four drug products to complete acquistion of Lannett
The U.S. Federal Trade Commission is requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc., the agency said on Thursday in a statement.
Consertus Earns Spot Among Nation's Leading Program Management Firms in ENR Rankings
MIAMI--(BUSINESS WIRE)--Consertus, Inc., a portfolio company of RTC Partners and a global capital program management and advisory firm, today announced that it has been recognized by Engineering News-Record (ENR), one of the construction industry's most respected publications, as one of the nation's leading program management firms. In ENR's 2026 rankings, Consertus earned a place on the Top 50 Pr
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology
FMC's rimisoxafen deal with Corteva aims to expand access to dual-mode herbicide technology for corn and soybean markets across the Americas.
Here's How Declining Crude Oil Prices are Benefiting Valero Energy
VLO could see stronger refining margins as crude prices decline, fuel demand stays resilient and global refining capacity remains tight.
ICUI or MDLN: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either ICU Medical (ICUI) or Medline (MDLN). But which of these two companies is the best option for those looking for undervalued stocks?
Estée Lauder Companies executive Kendal Ascher’s cause of death revealed - Cosmetics Business
VLO vs KMI: Which Energy Pick Offers a Better Investment Opportunity?
Valero's refining upside and discounted valuation stand out, while Kinder Morgan offers stable cash flows and exposure to U.S. natural gas growth.
Can SPB's Pet Care Segment Sustain Double-Digit Sales Growth?
Spectrum Brands' Pet Care segment posts double-digit sales growth in Q2, fueled by brand strength, innovation, e-commerce gains and market-share wins.
Bronstein, Gewirtz & Grossman LLC Urges Helen of Troy Limited Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, June 18, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Helen of Troy Limited (NASDAQ: HELE) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and ent
This $2 Million Portfolio Pays a Six-Figure Income Without Owning a Single Rental Property
A $2 million investment portfolio can generate a six-figure income stream without tenants, maintenance calls, property tax surprises, or vacancy risk. The arithmetic is straightforward. The challenge is deciding how much yield to pursue and understanding the trade-offs that come with it. To make a fair comparison, start with rental real estate. Many landlords aim... This $2 Million Portfolio Pays
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies
Jazz Pharmaceuticals teams up with AbCellera to discover and develop T-cell-engaging antibodies for GI cancers and other solid tumors.
FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens
The U.S. FDA on Thursday approved an expanded indication for Merck & Co Inc.'s (NYSE:MRK) Capvaxive, extending its use to children and adolescents ages 2–17 with chronic conditions who have completed a primary pneumococcal vaccine series.
Biogen To Acquire RayThera For Up To $1 Billion, Expanding Immunology Pipeline
Biogen acquires RayThera in a deal worth up to $1 billion, adding early-stage immunology assets as it expands beyond Alzheimer's disease.
3 Tobacco Stocks to Keep an Eye on Amid Market Headwinds
PM, BTI and MO are tackling volume pressures and rising costs by expanding smoke-free portfolios and adapting to changing consumer trends.
McCormick (MKC) Reports Next Week: What Awaits?
McCormick (MKC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout
BIIB is set to acquire RayThera for up to $1 billion, adding anti-inflammatory candidates that could expand its immunology pipeline and future growth.
ANGO Gains FDA IDE Approval for NanoKnife BPH Feasibility Study
AngioDynamics' FDA IDE approval for RELIEF advances NanoKnife IRE study as a potential minimally invasive BPH treatment.
Wall Street Analysts See a 39.86% Upside in Mama's Creations, Inc. (MAMA): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 39.9% in Mama's Creations, Inc. (MAMA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CastleKnight Management LP Buys 126,218 Shares of Energizer Holdings, Inc. $ENR - MarketBeat
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Valero Energy (VLO) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
The Andersons, Inc. Names David R. Heppner to Board of Directors
MAUMEE, Ohio, June 18, 2026 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE) has named David R. Heppner to the company's board of directors, effective June 18, 2026.
SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC
Alert: Claims Focus on Alleged Misrepresentations About Regencell's $1 Million R&D Budget Versus $14 Billion Market Valuation NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities of a pending securities class action. THE CASE: A class action was filed, seeking to recover damages for investors who purchased Regencell
Lost Money on Helen of Troy Limited (HELE)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
Alert: HELE Shares Lost Over $38 Per Share Across Three Corrective Disclosures as Project Pegasus Promises Collapsed Under the Weight of Concealed Operational Failures NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt alerts investors in Helen of Troy Limited (NASDAQ: HELE) of a pending securities class action. Class Period: April 24, 2024 through October 8, 2025.
Lost Money on Lucid Group, Inc. (LCID)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
Critical Information: $1.57 Per Share in Combined Losses Quantifies Alleged Investor Damages After Lucid Group Concealed a 29-Day Delivery Halt That Erased Significant Market Value NEW YORK, June 18, 2026 /PRNewswire/ -- SueWallSt reminds purchasers of Lucid Group, Inc. (NASDAQ: LCID) securities of a pending securities class action. THE CASE: A class action seeks to recover damages for investors w
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Celsius Holdings, Inc. - CELH
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Celsius Holdings, Inc. ("Celsius" or the "Company") (NASDAQ: CELH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Helen of Troy Limited of Class Action Lawsuit and Upcoming Deadlines - HELE
NEW YORK, June 18, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Helen of Troy Limited ("Helen of Troy" or the "Company") (NASDAQ: HELE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Ketch Named Grid Leader in G2 Summer 2026 Reports, Signaling Market Momentum and Enterprise Customer Trust
SAN FRANCISCO--(BUSINESS WIRE)--Ketch, the AI Privacy Company, today shared it has been named a Leader by G2, the world's largest and most trusted data source on B2B software, in its Summer 2026 Reports.Ketch earned 22 badges across 41 reports, including Momentum Leader designation in the categories of Consent Management Platforms (CMP), Data Privacy Management, Cookie Tracking, and Data Subject A
MiMedx Group Inc (MDXG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company's vision for transforming women's health President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company's vision for transforming women's health
Aristotle Capital Boston LLC Grows Stake in AptarGroup, Inc. $ATR - MarketBeat
Fujifilm Life Sciences at BIO 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Millions of patients worldwide still lack access to vital medicines. At BIO International Convention 2026, taking place June 22-25 at the San Diego Convention Center, Fujifilm's Life Sciences group will showcase how its integrated global ecosystem is helping biopharmaceutical innovators accelerate the path from discovery to delivery. The company's expanding life
Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food and animal safety solutions, today announced the expanded availability of FIFRA* Section 2(ee) recommendations for the use of Prozap® Insectrin X Concentrate and Prozap® Screw Worm and Ear Tick Aerosol as part of New World Screwworm (NWS) response efforts. These recommendations provide ranchers, livest
Regions Private Wealth Management Wins Two Global Private Banking Innovation Awards for Second Consecutive Year
[url="]Regions Bank[/url] on Thursday announced its [url="]Private Wealth Management division[/url] earned two top industry honors at the 2026 Global Private B
Wearable Devices Founder to Present “How Brain-Computer Interface is Removing the Friction from AR and AI Interaction” at AWE USA 2026
Guy Wagner, Founder and Chief Scientific Officer of Wearable Devices, will present the session on June 18, 2026, from 1:40 PM to 2:05 p.m. PT in Promenade Room 104B as part of the XR Enablement track at AWE USA 2026 YOKNEAM ILLIT, ISRAEL, June 18, 2026 (GLOBE NEWSWIRE) -- Wearable Devices Ltd.
UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics
Published in Nature Communications, the new study finds that nearly 70% of a common bacterial strain that causes urinary tract infections, pneumonia and wound infections was non-susceptible to the three most used oral antibiotics SECAUCUS, N.J., June 18, 2026 /PRNewswire/ -- A common bacterial strain that lives naturally in people's guts can cause a dangerous or deadly infection for some, especial
5 Stocks to Grab as Retail Sales Continue to Surge on Robust Demand
Retail sales rose for the fourth month as demand stayed strong, spotlighting CASY, FIVE, SBUX, TPR and TJX amid improving earnings estimates.
Boomers Need the Safest Dividend Stocks. We Asked Claude and Found 5 That Yield 5% or More
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
Armistice Capital LLC Takes $20.61 Million Position in Energizer Holdings, Inc. $ENR - MarketBeat
Cramer Gives Vistra His Blessing, Backs Stryker, Steers Clear Of AI-Exposed FICO
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying Vistra Corp. (NYSE:VST), adding it “went too high. It's come back down.
Nocera Highlights CampaignPulse.ai Platform Capabilities and Expanding AI Intelligence Opportunity Following Strategic Investment
Follow-Up Announcement Highlights CampaignPulse.ai 's Planned AI-Powered Campaign Intelligence Platform While Nocera Advances Integration of IRMA AI Technologies Through Its Pending Digital Innovations Group Partnership
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
WILMINGTON, Mass.--(BUSINESS WIRE)---- $CRL #LIFEatCRL--Charles River Laboratories International, Inc. (NYSE: CRL) announced a collaboration with Lilly TuneLab, a collaborative AI/ML drug discovery platform created by Eli Lilly and Company (Lilly). TuneLab was created to accelerate biotech innovation by enabling participating companies to access AI/ML drug discovery models trained on decades of Li
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026
Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical Manufacturing AGOURA HILLS, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB: OTLC) today announced the launch of its artificial intelligence ("AI") powered good manufacturing practices ("GMP") manufacturing services platfor
BIO-key's Fireside Chat at Maxim Group Defense Tech Conf. to Webcast Thur.
Biometric authentication provider BIO-key's (BKYI) CEO will participate in a webcast fireside chat at Maxim Group's Defense Tech Conf. 6-25 at 4pm, track 2
1 Dividend King And 1 Aristocrat Looking Poised For A Long-Term Rebound
PepsiCo, Inc. and Badger Meter, Inc. are high-quality dividend stocks trading below historical averages, offering compelling medium- to long-term upside. PEP faces near-term margin pressure from inflation but expects improved cash flow and growth from acquisitions like Poppi, with analysts targeting $200 by 2028. BMI's share price correction and debt-free balance sheet position it for growth via b
BioHarvest Sciences to Present at the 2026 BIO International Convention
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details: Session: Compa
Breckenridge Distillery Releases Limited Single Barrel Bourbon Collection
BRECKENRIDGE, Colo., June 18, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S., and a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), today announced the limited release of its Breckenridge Distillery Single Barrel Bourbon Collection.
Massive News for Celsius Stock Investors
Celsius (CELH +1.22%) is facing near-term headwinds impacting costs.
Elanco to Launch Elanco Ventures with $25 Million Multi-Year Commitment to Accelerate Innovation in Animal Health
New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutions INDIANAPOLIS, June 18, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance innovation in animal health. To be backed by a $25
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Medtronic offers high growth potential in addition to discounted valuation.
Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy
Refresh Your Energy with Hi*Ball Sparkling Energy Water, a bold new energy drink powered by natural caffeine and functional ingredients, with zero sugar, zero calories, and zero compromise.
Simply Good Foods to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, July 9, 2026
DENVER, June 18, 2026 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods” or the “Company”), a leader in the Nutritional Snacking category, today announced it will report financial results for the third quarter of Fiscal Year 2026 on Thursday, July 9, 2026. A press release will be issued that morning, followed by a live conference call beginning at 6:30 a.m. Mount
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026.
The $1.5 Million Portfolio That Out-Earns the Median U.S. Household
A $1.5 million portfolio is often treated as a wealth milestone. A more useful way to think about it is as a private pension, one capable of producing a steady stream of income long after your working years are over. The balance itself is only part of the story. What matters is how much cash... The $1.5 Million Portfolio That Out-Earns the Median U.S. Household
Merck's pneumococcal vaccine wins US approval for high-risk children, teens
Drugmaker Merck said on Thursday the U.S. health regulator has approved an expanded use of its pneumococcal vaccine for children and teenagers who face a higher risk of catching the bacterial disease due to chronic health conditions.
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine).
Alto Ingredients: This Small-Cap Turnaround Still Has Room To Run
Alto Ingredients has rallied more than 300% over the last year, but the stock still trades at a discount to the sector. Gross profit improved sharply year over year, helped by stronger crush margins, export demand, 45Z tax credits, and derivative gains. Scenario analysis shows ALTO trades at a 33–40% P/E discount to peers, with 2027 base and bull cases offering 73–98% upside; I rate it Strong Buy.
John B. Sanfilippo: Protein Bars Are Reshaping The Growth Story
John B. Sanfilippo & Son, Inc. is transitioning from traditional nut sales to focus on contract manufacturing and protein bar production. Despite retail sales declines from inflation, JBSS is executing a substantial capex plan to drive profitability in higher-margin sectors. The market is currently mispricing JBSS by overlooking the transformative impact of its capital investments.
Philip Morris International Announces New Regional Leadership
Philip Morris International (PMI) (NYSE: PM) announced a series of regional leadership appointments that support its ongoing shift toward a smokeâfree future
My Top 5 Dividend Picks For June
Keurig Dr Pepper, Novo Nordisk, Sonoco Products, Domino's Pizza, and Realty Income are top June dividend picks, all rated Buy or Strong Buy. KDP, NVO, SON, DPZ, and O are each trading 15–37% below estimated fair value, offering yields averaging 3.78% and projected annual returns of ~14%. I expect robust dividend growth and improving margins across these picks, with strong balance sheets and resili
What Led Multi-Color Corporation to Chapter 11 - Kavout
Statkraft and Alcoa sign new power agreements to secure energy supply for the aluminium plant in Southern Norway
(Oslo/Lista, Norway 18 June 2026) Statkraft and Alcoa have signed two new power agreements securing electricity supply to support continued operation of Alcoa's aluminium plant at Lista, Norway. The agreements provide a solid and predictable energy foundation for the smelter and help maintain both production and further development at the site. Production Line 2 at Lista recently completed a succe
Coca-Cola: There's Still Some Upside Despite Emerging Technical Caution
The Coca-Cola Company demonstrates resilience amid inflation and macro volatility, supported by a robust product portfolio and asset-light business model. KO delivered double-digit revenue growth in Q1 2026 and expanded operating margins, with pricing flexibility and global market segmentation key to performance. Valuation is reasonable, with KO trading at 25.25x P/E and target prices ranging from
Three must-own dividend stocks irrespective of the broader market trajectory
Wall Street's careening trajectory has left investors grappling with a highly volatile macro climate. Despite brief relief from a tentative US-Iran ceasefire, the Federal Reserve's latest Summary of Economic Projections paints a hawkish picture – slashing GDP expectations while projecting sticky PCE inflation at 3.6%.
Is Simply Good Foods Stock Too Cheap to Pass Up?
Simply Good Foods trades at 7.1 times forward earnings and 7.8 times free cash flow after a 62% price drop. Management is repositioning Atkins as a complement to GLP-1 weight-loss drugs rather than a competitor.
The Estée Lauder Companies Receives Outstanding Poster Award for Scalp Longevity Research at the 2026 World Congress for Hair Research - The Estée Lauder Companies Inc.
MiMedx Shareholders Back Board, Pay and Bylaw Changes - The Globe and Mail
Estée Lauder Companies and Jo Malone Create Personalized Fragrance Wardrobe - Happi | Household And Personal Products Industry
James Campbell Company Expands Portfolio with Acquisition of Multifamily Property, The Element, in West O‘ahu
KAPOLEI, Hawai‘i--(BUSINESS WIRE)--James Campbell Company expands its portfolio with the acquisition of a multifamily property called The Element in West O‘ahu.
Dixie Gold Inc. Appoints Chief Executive Officer and Director, Obtains Extension to Notice of Deficiency
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Dixie Gold Inc. (TSXV: DG) ("Dixie Gold" or the "Issuer") reports on matters pertaining to the Issuer. Appointment of a Chief Executive Officer (CEO) and a Director The Issuer reports that a candidate for the Issuer's vacant Chief Executive Officer (CEO) position approached the Issuer and, after a diligence review of the candidate by
Freshpet (FRPT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Freshpet (FRPT) closed at $55.66 in the latest trading session, marking a -2.5% move from the prior day.
Biogen to acquire RayThera for $1 billion
Biogen said on Wednesday it would acquire drug discovery company RayThera for $1 billion, including milestone payments.
Why Archer Daniels Midland (ADM) Dipped More Than Broader Market Today
Archer Daniels Midland (ADM) concluded the recent trading session at $76.5, signifying a -1.95% move from its prior day's close.